Biotech

Viaderma Inc (OTCMKTS:VDRM) shares rose 38.60% on Friday to $0.00790 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.02. The company has a market cap of $2.73 million at 200.32 million shares outstanding. Viaderma Inc is a pharmaceutical company focused on...

Healthcare is hot right now, and there's no hotter space from a fund perspective than oncology. Here's a look at the Vertical Fund's latest equity acquisition, a position taken in small cap cancer focus biotech, Oncomed. In a just published Form 13, filed with the US Securities and Exchange Commission...

Palo Alto has been busy in the healthcare sector over the last couple of days. Here's a look at the fund's second healthcare filing of the day, and what it means for the company involved. In a just published Form 13, filed with the US Securities and Exchange Commission (SEC),...

With JP Morgan out of the way, it's time for the biotechnology space to return to normality. Well, normality, that is, as far as the biotech space can be normal. There remains a host of catalysts and data drops on the calendar, and these have the potential to drive...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Kindred Biosciences Inc. (NASDAQ:KIN) reported that Park West Asset Management has picked up 2,274,138 of common stock as of 2017-01-12. The acquisition brings the aggregate amount owned by Park West Asset Management to a total...